Early predictors of 15-year end-stage renal disease in hypertensive patients.
about
Overweight, obesity, and elevated serum cystatin C levels in adults in the United StatesThe cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizationsIdentifying and slowing progressive chronic renal failureEnd-stage renal disease in Taiwan: a case-control studyAssociation of body mass index with outcomes in patients with CKD.End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study.Renal surrogates in essential hypertension.Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP)The kidney as a target of hypertension.Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?The need to lower systolic blood pressure.Slowing the progression of renal disease in diabetic patients.The state of U.S. living kidney donors.Non-interventional management of resistant hypertension.Benefits from treatment and control of patients with resistant hypertension.Adiposity patterns and the risk for ESRD in postmenopausal womenIncident chronic kidney disease and newly developed complications related to renal dysfunction in an elderly population during 5 years: a community-based elderly population cohort study.Applying multiple interventions in chronic kidney disease.Therapeutic effect of continuous exercise training program on serum creatinine concentration in men with hypertension: a randomized controlled trial.Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study.Hypertension in Cardiovascular and Kidney Disease.Blood pressure control and nephroprotection in diabetes.Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.Managing high-risk patients with hypertension: focus on the renin-angiotensin system.The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney DiseaseAssociation between dietary salt intake and reservation of renal function in patients with mild hypertension.Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort studyManagement of hypertensive chronic kidney disease: role of calcium channel blockers.Bidirectional association between ESRD dialysis and diabetes: National cohort studyClinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney DiseaseHypertension and kidney disease: a deadly connection.Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same?Body mass index in 1.2 million adolescents and risk for end-stage renal disease.Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.Inhibition of the renin-angiotensin system and chronic kidney disease.Characteristics of uninsured Americans with chronic kidney disease
P2860
Q24607254-AB309636-DD85-440C-8FBC-7A8FA3F891D7Q28208693-5FFF023E-B536-4C56-A2C9-7C9879FF6746Q28344781-FA49480C-3711-4524-8991-756817720BB3Q28395995-99D1CEF1-820B-41A3-A050-EA1494C90812Q30371128-96C9A588-F3D8-408D-B9D5-CA9CA4DE0468Q30939425-61E6A12C-36CE-46C1-AD97-2E2F2FBBF14FQ33697583-B21E544C-0E7A-4C8D-9900-4C39E19AD1CAQ33983415-84FB1D00-0C82-4E0F-9739-6FB618CB5185Q34028197-7604D079-DB2C-40E8-9435-D944156724C0Q34028499-5BB2966C-A544-4F5B-8E92-53CD56ABCACEQ34028532-FAC4C8D9-AA58-40AE-892C-4669BB9838ECQ34038034-A730CB77-031E-4848-97DC-B80A9A2566A2Q34219071-B328A4E5-01FF-4692-9F2D-A0261403E84AQ34281425-99EAA11F-EC73-430E-9211-8F7E4119029BQ34404475-2AC09B4E-5079-4F76-9BF4-1ED9DCFA8606Q34460638-A58D946E-DF92-43BD-B453-2A68F7745B58Q35051169-BB796BCC-6EC7-43BB-BD5A-36BF513871CBQ35075773-026ABB08-F9E9-46AE-929D-0CBDF5F02D9CQ35086974-D50DD5F5-9853-40FF-A4E8-FDA975C2E1E4Q35104626-80E10F1E-231C-4FF1-9E65-34CB6322FE10Q35113482-47E99232-2BE3-47A1-958D-6910CD43ED48Q35137813-ACF93912-BFB6-4322-AC5B-488BEE8762B3Q35203404-38977B90-43AF-44F0-9DD5-0E8AEB1C70EEQ35722933-6334F788-5518-47EE-A6FF-724FE2CC5986Q35837912-D07B4C27-579B-42C9-B35E-620AA57E7DB6Q35886386-E921D3ED-9F8F-4114-A2C7-491C7FCC7698Q35914820-161ABA46-D96D-4BB2-AC1C-BA75BC3922C4Q35933646-32267CCC-EF7B-4F4C-ABED-B354D80A96FEQ35986230-84BA5B7E-7013-4147-AE9F-35E83E091F71Q36109573-75422588-BDDB-4681-AB81-1889F505F304Q36309097-6E0D6443-CB7A-4661-80F7-98F50AEF8E7AQ36359500-0689915D-5875-49B3-AD55-2952BBF2D55CQ36575572-2A20A008-2B58-4CEC-AEDB-C2A4E92A7C95Q36632424-57B91EE9-AC91-411C-B81E-1E2FB7758EE0Q36865845-FA859E22-804F-471D-9BB1-95C6EEC71D69Q37030762-6A87222F-A7E0-41CF-A9B4-040456394A61Q37085746-CE3C32B9-A0BB-422A-BBD4-1812FF57E45EQ37165278-0743BA0C-A801-42AC-B02C-CDA661EFA003Q37243981-63E170D5-B0EF-4B71-B9C4-603624FA640DQ37261346-E8F43B2F-530A-4E32-93AC-87E29AA6349C
P2860
Early predictors of 15-year end-stage renal disease in hypertensive patients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Early predictors of 15-year end-stage renal disease in hypertensive patients.
@en
Early predictors of 15-year end-stage renal disease in hypertensive patients.
@nl
type
label
Early predictors of 15-year end-stage renal disease in hypertensive patients.
@en
Early predictors of 15-year end-stage renal disease in hypertensive patients.
@nl
prefLabel
Early predictors of 15-year end-stage renal disease in hypertensive patients.
@en
Early predictors of 15-year end-stage renal disease in hypertensive patients.
@nl
P2093
P356
P1433
P1476
Early predictors of 15-year end-stage renal disease in hypertensive patients.
@en
P2093
D W Moskowitz
J P Miller
J R Fornoff
M P Sambhi
S E Carmody
P304
P356
10.1161/01.HYP.25.4.587
P407
P433
P577
1995-04-01T00:00:00Z